<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this investigation was to explore the expression of nm23-H(1) gene in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and evaluate the relationship between nm23-H(1) expression and therapeutic outcomes </plain></SENT>
<SENT sid="1" pm="."><plain>Semi-quantitative RT-PCR was used to detect the expression of nm23-H(1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> in marrow mononuclear cells from 28 MDS patients and 15 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="2" pm="."><plain>nm23-H(1)/GAPDH ratio &gt;/= 0.5 was believed to a positive case </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of nm23-H(1) was positive in 24 of 28 MDS patients, and the average level was 0.89 +/- 0.56 </plain></SENT>
<SENT sid="4" pm="."><plain>nm23-H(1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> was negative in <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="5" pm="."><plain>The overexpression of nm23-H(1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients could predict outcome of treatment and prognosis for <z:chebi fb="14" ids="53218">MDR</z:chebi> patients </plain></SENT>
</text></document>